Impact of contrast echocardiography on diagnostic algorithms: Pharmacoeconomic implications

Clinical Cardiology

Volumn 20, Issue 10 SUPPL., 1997, Pages

  Shaw, Leslee J ^a,b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Contrast echocardiography; Cost effectiveness; Diagnostic algorithms; Disease management; EchoGen ; Economics; Patient outcomes

Indexed keywords

ALBUNEX; CONTRAST MEDIUM; PERFLUOROPENTANE;

ALGORITHM; CLINICAL TRIAL; CONTRAST ECHOCARDIOGRAPHY; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG COST; ECHOCARDIOGRAPHY; HEART MUSCLE ISCHEMIA; HUMAN; OUTCOMES RESEARCH; PEROPERATIVE ECHOGRAPHY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0030667969     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960201309     Document Type: Review

References (68)

1. Kassirer J: Managed care and the moralily of the marketplace. N Engl J Med 1995;333:50-52
2. Marmion M, Deutsch E: Tracers and contrast agents in cardiovascular imaging: Present and future. J Nucl Biol Med 1996;40: 121-131
3. Patterson RE, Horowitz SF, Eisner RL: Comparison of modalities to diagnose coronary artery disease. Semin Nucl Med 1994;XXIV: 286-310
4. Feigenbaum H: Evolution of echocardiography. Circulation 1996; 93:1321-1327
5. Reichek N: Two-dimensional echocardiography for determination of left ventricular mass. Am J Cardiol Imag 1994;8:305-309
6. ™ emulsion: A new ultrasound contrast agent based on phase shift colloids. Clin Radiol 1996; 51(suppl 1):11-14
7. Coulden R, Lipton MJ: Noninvasive imaging for the diagnosis and management of myocardial ischemia. Adv Cardiol Surg 1993; 4:173-205
8. Stollfuss JC, Kosa I, Ziegler S, Schwanger M: Quantitative assessment of myocardial perfusion: Is it of clinical significance? Q J Nucl Med 1996;40:76-84
9. Feigenbaum H: Echocardiography and coronary artery disease. Int J Cardiol Image 1993;9(suppl 2):55-67
10. Chaitman BR: The changing role of the exercise electrocardiogram as a diagnostic and prognostic test for chronic ischemic heart disease. J Am Coll Cardiol 1986;8:1195-1210
11. Shaw LJ, Peterson ED, Kesler K, Hasselblad V, Califf RM: A metaanalysis of predischarge risk stratification after acute myocardial infarction with stress electrocardiographic, myocardial perfusion, and ventricular function imaging. Am J Cardiol 1996;78: 1327-1337
12. Hachamovitch R, Berman DS, Kiat H, Cohen I, Cabico JA, Friedman J, Diamond GA: Exercise myocardial perfusion SPECT in patients without known coronary artery disease. Circulation 1996;93:905-914
13. Marwick TH: Recent advances in stress echocardiography. Curr Opin Cardiol 1995;10:619-625
14. Berman DS, Hachamovitch R, Kiat H, Cohen I, Cabico JA, Wang FP, Friedman JD, Germano G, Van Train K, Diamond GA: Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: A basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1995; 26:639-647
15. Armstrong W, Marwick T, Pellika R, Ryan T, Segar D, Lewandowki T, Rubin D, Das M, Lim C, Maxted W: Albunex improves agreement between experienced and less-experienced echocardiographers for the evaluation of left ventricular wall motion during bicycle stress echocardiography. J Am Soc Echocardiogr 1997;10:393
16. Patterson RE, Eisner RL, Horowitz SF: Coronary artery disease/ myocardial infarction: Comparison of cost effectiveness and utility of exercise ECG, single photon emission computed tomography, positron emission tomography, and coronary angiography for diagnosis of coronary artery disease. Circulation 1995;91:54-65
17. Califf RM, Harrell FE Jr, Lee KL, Rankin JS, Hlatky MA, Mark DB, Jones RH, Muhlbaier LH, Oldham HN Jr, Pryor DB: The evolution of medical and surgical therapy for coronary artery disease. A 15-year perspective. J Am Med Assoc 1989;261(14):2077-2086
18. American College of Cardiology Database. ACC Homepage (www.acc.org); 1996
19. Shaw LJ, Kesler K, Eisenstein EL, Heller GV, Travin MI, Duca MD, Taillefer R, Miller DD, for the Economics of Noninvasive Diagnosis (END) Multicenter Study Group: A multicenter study of 11,372 patients to examine cost-effective strategies for diagnosis of coronary artery disease. J Am Coll Cardiol 1996;27:286A
20. Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, Friedman J, Diamond GA: The prediction of myocardial infarction versus cardiac death by myocardial perfusion SPECT: Strategic and therapeutic implications. Circulation 1997 (in press)
21. Marwick TH, Nemec JJ, Pashkow J, Stewart WJ, Salcedo EE: Accuracy and limitations of exercise echocardiography in a routine clinical setting. J Am Coll Cardiol 1992;19:74-81
22. Picano E, Lattanzi F: Dipyridamole echocardiography: A new diagnostic window on coronary artery disease. Circulation 1991; 83:III,19-26
23. Kaul S: Myocardial contrast echocardiography in coronary artery disease: Potential applications using venous injections of contrast. Am J Cardiol 1995;75:61D-68D
24. Angermann CE, Krüger TM, Junge R, Drewello R, Stempfle HU, Spes CH, Theisen K: Intravenous albunex during transesophageal echocardiography: Quantitative assessment by videodensitometry and integrated backscatter analysis from unprocessed radiofrequency signals. J Am Soc Echocardiogr 1995;8:839-853
25. Crouse LJ, Cheirif J, Hanly DE, Kisslo JA, Labovitz AJ, Raichlen JS, Schutz RW, Shah PM, Smith MD: Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: Results of the phase III albunex multicenter trial. J Am Coll Canliol 1993;22: 1494-1500
26. Tokgözoglu SL, Caner B, Kabakci G, Kes S: Measurement of right ventricular ejection fraction by contrast echocardiography. Int J Cardiol 1997;59:71-74
27. Villanueva FS, Kaul S: Assessment of myocardial perfusion in coronary artery disease using myocardial contrast echocardiography. Coron Artery Dis 1995;6:18-28
28. Hu BS, Saltiel F, Popp RL: Effectiveness of limited training in echocardiography for cardiovascular diagnosis (abstr). Circulation 1996;94:I-253
29. AHA Heart Facts. Chicago, Ill.: American Hospital Publishing Inc., publication; 1995
30. Heupler S, Mehta R, Lobo A, Leung D, Marwick TH: Prognostic implications of exercise echocardiography in women with known or suspected coronary artery disease. J Am Coll Cardiol 1997;30: 414-420
31. Kelsey A, Shaw LJ, Lim SC, Ryan T: Fifteen years of exercise echocardiography: A meta-analysis. Circulation 1997 (in press)
32. Vasan RS, Larson MO, Benjamin EJ, Evans JC, Levy D: Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med 1997;336: 1350-1355
33. St. John Sutton M, Pfeffer MA, Plappert T, Rouleau J-L, Moyé LA, Dagenais GR, Lamas GA, Klein M, Sussex B, Goldman S, Menapace PJ Jr, Parker JO, Lewis S, Sestier F, Gordon DF, McEwan P, Bernstein V, Braunwald E: Quantitative two-dimensional echocardiographic measurements arc major predictors of adverse cardiovascular events after acute myocardial infarction. The protection effects of captopril. Circulation 1994;89:68-75
34. Rubin DM, Haluska B, Morehead A, Marwick TH: Improving bicycle stress echo image quality with Albunex. J Am Coll Cardiol 1997;29:260A
35. Villarraga HR, Foley DA, Mulvagh SL: Contrast echocardiography 1996: A review. Tex Heart Inst J 1996;23:90-97
36. Cohen J, Bruns E, Hausner E, Gottdiener J, Dick C, Picard M, Crouse L, for the FS069 Multi-Center Study Group: Multicenter trial comparing FS069 and albunex for left ventricular endocardial border delineation. J Am Coll Cardiol 1997;29:519A
37. Kangarloo H, Ho BK, Lufkin RB, Barbaric Z, Kirlew K, Yaghmai S, Scholem D, Steckel RJ: Effect of conversion from a fee-for-service plan to a capitation reimbursement system on a circumscribed outpatient radiology practice of 20,000 persons. Radiology 1996; 201(1):79-84
38. Grayburn PA: How good is echocardiography at assessing myocaridal viability? Am J Cardiol 1995;76:1183-1184
39. Bonow RO: Identification of viable myocardium. Circulation 1996;94:2674-2680
40. Cheirif J, Meza M, Murgo JP: Dobutamine echocardiography and myocardial contrast echocardiography: Two new techniques for the assessment of myocardial viability. Tex Heart Inst J 1995;22:33-39
41. Nanto S, Lim Y-J, Masuyama T, Hori M, Nagata S: Diagnostic performance of myocardial contrast echocardiography for detection of stunned myocardium. J Am Soc Echocardiogr 1995;9:314-319
42. Nallamouthu N, Araujo L, Russell J, Heo J, Iskandrian AD: Prognostic value of simultaneous perfusion and function assessment using technetium-99m sestamibi. Am J Cardiol 1996;78:562-564
43. Shaw LJ, Heinle SK, Borges-Neto S, Kesler K, Coleman E, Jones RH, for the Duke Noninvasive Research Working Group: Prognosis in patients with coronary amage quality with Albunex. J Am Coll Cardiol 1997;29:260A
44. Fetters J, Peterson ED, Shaw LJ, Newby LK, Califf RM: Sex-specific differences in coronary artery disease risk factors, evaluation, and treatment: Have they been adequately evaluated? Am Heart J 1996;131:796-813
45. Peterson ED, Shaw LJ, Oddone E: An empirical approach to evaluation of chest pain in women. J Clin Outcomes Manag 1995;2: 9-23
46. Shaw LJ, Miller DD, Romeis JC, Kargl D, Younis LT, Chaitman BR: Gender differences in the noninvasive evaluation and management of patients with suspected coronary artery disease. Ann Intern Med 1994;120:559-566
47. Mark DB, Shaw L, Delong ER, Califf RM, Pryor DB: Absence of sex bias in the referral of patients for cardiac catheterization. N Engl J Med 1994;330:1101-1106
48. Hlatky MA, Pryor DB, Harrell FE Jr, Califf RM, Mark DB, Rosati RA: Factors affecting sensitivity and specificity of exercise echocardiography: Multivariable analysis. Am J Med 1984;77:64-71
49. Barolsky SM, Gilbert CA, Faruqui A, Nutter DO, Schlant RC: Differences in electrocardiographic responses to exercise of women and men: A non-Baycsian factor. Circulation 1979;60:1021-1027
50. Johnson LL: Sex-specific issues relating to nuclear cardiology. J Nucl Cardiol 1995l2:339-348
51. Shaw LJ, Kesler K, Peterson ED, Delong ER, Borges-Neto S, Califf RM, for the Duke Noninvasive Research Working Group: Long-term prognostic implications of abnormal stress electrocardiographic or myocardial perfusion scintigraphic measures in patients with angiographically-insignificant coronary artery disease. J Am Coll Cardiol 1996;27:78A
52. Peterson ED, Shaw LJ, Califf RM: Risk stratification after myocardial infarction. Ann Intern Med 1997;126:561-582
53. Wackers FJT, Heller GV, Sotwers S, Hendel RC, Herman S, Baron J, Daher E, for the Acute Chest Pain Tetrofosmin Trial: Normal rest tetrofosmin SPECT imaging in patients with chest pain and normal or nondiagnostic ECG in the emergency department is associated with lower need for subsequent cardiac catheterization and revascularization. J Am Coll Cardiol 1997;29:196A
54. Bilodeau L, Théroux P, Gregoire J, Gagnon D, Arsenault A: Technetium-99m sestamibi tomography in patients with spontaneous chest pain: Correlations with clinical, electrocardiographic and angiographic findings. J Am Coll Cardiol 1991;18:1684-1691
55. Braunwald E, Mark DB, Jones RH, Archibald N, McCauley KM, Smith EE III, Green LA, Cheitlin MD, Swain JA, Morrison DA, Edwards C, Brown L, Goldman L, Fuster V, Cowan M, Grines CL, Rose GC, Topol EJ, Concannon CA, Lytle BW, Willerson JT, Mushlin AI: Clinical practice guideline number 10: Evaluation instruments for the care of patients with unstable angina. U.S. DHHS. PHS, Washington, DC. AHCPR Publication No. 95-0602
56. Newby LK, Califf RM, Guerci A, Weaver WD, Col J, Horgan JH, Mark DB, Stebbins A, Van de Werf F, Gore JM, Topol EJ: Early discharge in the thrombolytic era: An analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) trial. J Am Coll Cardiol 1996;27:625-632
57. Fleischmann KF, Goldman L, Robiolio PA, Lee RT, Johnson PA, Cook EF, Lee TH: Echocardiographic correlates of survival in patients with chest pain. J Am Coll Cardiol 1994;23:1390-1396
58. Villanueva FS, Camarano G, Ismail S, Goodman NC, Sklenar J, Kaul S: Coronary reserve abnormalities in the infarcted myocardium: Assessment of myocardial viability immediately versus late after reflow by contrast echocardiography. Circulation 1996;94: 748-754
59. Christian TF, Clements IP, Gibbons RJ: Noninvasive identification of myocardium at risk with acute myocardial infarction and nondiagnostic electrocardiograms with technetium-99m-sestamibi. Circulation 1994;89:1615-1620
60. Eagle KA, Brundage BH, Chaitman BR, Ewy GA, Fleisher LA, Hertzer NR, Leppo JA, Ryan T, Schlant RC, Spencer WH III, Spittell JA Jr, Twiss RD, Ritchie JL, Cheitlin MD, Gardner TJ, Garson A Jr, Lewis RP, Gibbons RJ, O'Rourke RA, Ryan TJ: Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery. Circulation 1996;93:1278-1317
61. Shaw LJ, Eagle KA, Gersh BJ, Miller DD: Meta-analysis of intravenous dipyridamole thallium-201 imaging (1985-1994) and dobutamine echocardiography (1990-1994) for risk stratification prior to vascular surgery. J Am Coll Cardiol 1996;27:787-798
62. Shaw LJ, Hachamovitch R, Eisenstein E, Berman D, Cohen M, Udelson J, Miller DD: Cost implications for implementing a selective preoperative risk screening approach for peripheral vascular surgery patients. Am J Managed Care (in press)
63. Wellman G, Sherrin T: Applying principles of pharmacoeconomic evaluation to perflenapent emulsion, a new echocardiographic contrast agent used in cardiac function testing. Clin Ther 1997;19: 837-846 (in press)
64. Laupacis A, Feeny D, Detsky AS, Tugwell PX: How attractive does a new technology have to be to warrant adoption and utilization?: Tentative guidelines for using clinical and economic evaluations. Can Med Assoc J 1992;146:473-481
65. Goldman L, Garber AM, Grover SA, Hlatky MA: Task Force 6. Cost effectiveness of assessment and management of risk factors. J Am Coll Cardiol 1996;27:1020-1030
66. Shaw LJ, Dittrich HC, Crouse LJ, Dent J, for the FS069 Multi-Center Study Group: Use of intravenous Optison contrast echocardiography reduces downstream resource use and enhances cost savings. Presented at the 11th Annual Symposium on Advances in Echocardiography, 1996
67. Hsiah A, Jollis JG, Kesler KL, DeLong ER, Collins M, Donovan CL, Waugh RA, Ryan T, Kisslo J: Prognostic value of transthoracic echo in the Duke Cardiovascular Disease Database. Circulation 1996;94:1-27
68. Shaw LJ, Dittrich HC: Use of intravenous Optison contrast echocardiography reduces downstream resource use and enhances cost savings. Acad Radiol 1997 (in press)